Patent details

EP3169357 Title: MODIFIED MENINGOCOCCAL FHBP POLYPEPTIDES

Basic Information

Publication number:
EP3169357
PCT Application Number:
EP2015066228
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP157383522
PCT Publication Number:
WO2016008960
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
MODIFIED MENINGOCOCCAL FHBP POLYPEPTIDES
French Title of Invention:
POLYPEPTIDES FHBP MÉNINGOCOCCIQUES MODIFIÉS
German Title of Invention:
MODIFIZIERTE MENINGOKOKKEN-FHBP-POLYPEPTIDE
SPC Number:

Dates

Filing date:
16/07/2015
Grant date:
07/11/2018
EP Publication Date:
24/05/2017
PCT Publication Date:
21/01/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/11/2018
EP B1 Publication Date:
07/11/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
16/07/2019
Expiration date:
16/07/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
31/10/2018
 
 

Name:
GlaxoSmithKline Biologicals S.A.
Address:
Rue de l'Institut, 89, 1330 Rixensart Brussels, Belgium (BE)

Inventor

1

Name:
BOTTOMLEY, Matthew
Address:
Italy (IT)

2

Name:
MASIGNANI, Vega
Address:
Italy (IT)

Priority

Priority Number:
14177564
Priority Date:
17/07/2014
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 39/095; C07K 14/22;

Publication

European Patent Bulletin

Issue number:
201845
Publication date:
07/11/2018
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages